Skip to content
  • Visit Patient Website
PROCEPT BioRobotics
  • About Us
  • Healthcare Providers
    • Overview
    • Aquablation Therapy
    • HYDROS Robotic System
    • Clinical Data
    • Reimbursement 
    • Resources
    • Government Hospitals
      • Overview
      • Aquablation Therapy
      • AquaBeam Robotic System
  • Investors
  • Careers
    • Overview
    • Our Teams
      • Sales and Marketing
      • Manufacturing
      • Medical Device Engineering
      • More Teams
    • Development & Learning
    • Life @ PROCEPT
    • Current Openings
  • Contact Us
  • Visit Patient Website

Compliance

The following links will take you to the key compliance documents publicized by PROCEPT BIOROBOTICS to satisfy its legal obligations under various Compliance laws and regulation

CA Compliance

CA Supply Chain Transparency Disclosure Statement

Declaration of Conformity for HYDROS® Robotic System

Risk and Safety Information

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation® therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the HYDROS® Robotic System or the AquaBeam® Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

As with any surgical urologic procedure, potential perioperative risks of the Aquablation procedure include but are not limited to the following, some of which may lead to serious outcomes and may require intervention: Anesthesia risk, Bladder or prostate capsule perforation, Bladder neck contracture, Bleeding or blood in the urine, Bruising, Penile or pelvic pain, Irritative symptoms, which may include dysuria, urgency or frequency, Infection, Transurethral resection (TUR) syndrome, Electric shock/burn, Urethral damage causing false passage or stricture, Rectal incontinence/perforation, Sexual dysfunction, including ejaculatory and erectile dysfunction, Incontinence or overactive bladder, Embolism, Urinary Retention.

Rx Only

Links

  • About Us
  • Aquablation Therapy
  • Careers
  • Clinical Data
  • Contact Us
  • Investors

Links

  • Patents
  • Patient Website
  • Safety Information
  • Terms Of Use
  • Trademark Guidelines
  • Privacy
  • Compliance
  • Sitemap

Follow us on social media

  • LinkedIn
  • Facebook
  • X
© 2026 PROCEPT BioRobotics Corporation. All rights reserved. AQUABLATION, AquaBeam, HYDROS, FirstAssist AI, PROCEPT BioRobotics, and the PROCEPT BioRobotics logo are trademarks and/or registered trademarks of PROCEPT BioRobotics Corporation in the U.S. and other countries and regions. ML0560.B